Shopping Cart
- Remove All
Your shopping cart is currently empty
Targocil is used as a bacteriostatic inhibitor of wall teichoic acid (WTA) biosynthesis which can inhibit the growth of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (MIC90s: 2 μg/ mL) for both MRSA and MSSA.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $35 | In Stock | |
| 5 mg | $59 | In Stock | |
| 10 mg | $94 | In Stock | |
| 25 mg | $176 | In Stock | |
| 50 mg | $286 | In Stock | |
| 100 mg | $401 | In Stock | |
| 200 mg | $562 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $59 | In Stock |
| Description | Targocil is used as a bacteriostatic inhibitor of wall teichoic acid (WTA) biosynthesis which can inhibit the growth of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (MIC90s: 2 μg/ mL) for both MRSA and MSSA. |
| Targets&IC50 | MSSA:2 μg/mL (MIC90), MRSA:2 μg/mL (MIC90) |
| In vitro | Targocil can inhibit the growth of S. aureus strains Newman, MG2375, MW2, and MG2389 (MICs: 1 μg/mL). Targocil has obviously activity against S. aureus isolates from suspected cases of bacterial keratitis, including both MSSA and MRSA isolates (MICs: 1-2 μg/ mL). Compare to the vehicle alone, Targocil (5 μg/mL) exhibits little toxicity for HCECs, even after 24 h of exposure. However, 40 μg/mL Targocil shows toxicity at all time points tested. In the presence of HCECs, Targocil at levels equal to 10×MIC in vitro readily inhibits the growth of MG2375 and Newman. |
| Molecular Weight | 475.95 |
| Formula | C21H22ClN5O4S |
| Cas No. | 1200443-21-5 |
| Smiles | CCN(CC)c1nc2c(nnn2c2cc(OC)c(OC)cc12)S(=O)(=O)c1ccc(Cl)cc1 |
| Relative Density. | no data available |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: Slightly soluble |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.